The Centers for Medicare and Medicaid Services (CMS) released an MLN Matters article MM13429 to notify physicians, hospitals and other providers billing Medicare Administrative Contractors (MACs) of its decision to retire National Coverage Determination (NCD) 220.6.20. As a result of this NCD reconsideration, CMS is ending coverage with evidence development (CED), removing the once-in-a-lifetime requirement for PET beta-amyloid imaging, and permitting Medicare coverage determinations for PET beta-amyloid imaging to be made by the MACs. As previously reported, CMS believes there will be consistent coverage across regions for appropriate Medicare patients, based on the evidence. The American College of Radiology® (ACR®) supports these final changes in coverage and hopes it will allow patients greater access to amyloid PET scans for Alzheimer’s disease diagnosis, management and evaluation of newly approved therapies.
Effective for claims with dates of service on and after Oct. 13, 2023, MACs will make coverage determinations for PET beta-amyloid imaging for dementia and neurodegenerative disease NCD 220.6.20. The contractors have until Dec. 19, to implement this policy change.
CMS indicates in transmittal 12364 that effective for claims with dates of service on and after Oct. 13, contractors will adjust any PET beta-amyloid claims processed incorrectly that are brought to their attention. Providers and/or billing and coding staff need to contact their MAC to clarify billing requirements for Beta Amyloid Positron Emission Tomography (PET) in dementia and neurodegenerative disease.
CMS Resources
If you have questions about the final coverage decision or the NCD process, contact Alicia Blakey, ACR Principal Economic Policy Analyst.
ACR Joins Letter Urging $51.3 Billion for NIH in FY27
ACR urged Congress to provide at least $51.3 billion in funding for NIH in federal fiscal year 2027.
Read moreACR Achieves MUE Increase for 3D-Printed Add-on Codes
CMS raised MUEs for 3Dâprinted model and guide codes after ACRâs appeal, aligning units with clinical needs for complex surgical planning.
Read moreACR Partners with Fight CRC for United in Blue
ACR joins Fight CRCâs 2026 United in Blue on the National Mall, supporting awareness, early detection, and colorectal cancer advocacy.
Read more
